Valuation: Cellink AB

Market Cap 1.67B 167M 149M 139M 126M 239M 16.19B 240M 655M 8.25B 628M 614M 26.49B P/E 2026 *
-7.36x
P/E 2027 * -13.2x
Enterprise Value 1.6B 160M 143M 133M 121M 229M 15.52B 230M 628M 7.91B 602M 589M 25.39B EV / Sales 2026 *
0.99x
EV / Sales 2027 * 0.89x
Free-Float
69.88%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 51 2026-08-31
Director of Finance/CFO 56 2026-02-28
Chief Operating Officer - 2026-01-06
Director TitleAgeSince
Director/Board Member 71 2019-12-17
Director/Board Member 37 2015-02-28
Director/Board Member 51 2026-05-06
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 167M
+0.93%+0.49%+25.38%+32.63% 243B
+1.08%+2.69%+8.57%+0.50% 155B
+2.06%+8.17%-1.31%+42.35% 150B
+1.64%+0.31%-55.21%-20.58% 61.93B
+1.15%+0.07%+15.24%+16.87% 49.12B
+2.30%+3.38%-17.09%-19.05% 48.78B
+1.41%+1.65%+24.83%+50.53% 48.08B
+3.96%+8.34%+3.33%+38.46% 47.95B
+1.08%+2.01%+31.05%+61.37% 42.62B
Average +1.56%+2.82%+3.86%+22.57% 94.01B
Weighted average by Cap. +1.51%+2.75%+7.65%+23.49%

Financials

2026 *2027 *
Net sales 1.62B 162M 145M 135M 123M 231M 15.7B 232M 636M 8B 609M 596M 25.68B 1.69B 169M 151M 140M 127M 241M 16.31B 242M 660M 8.32B 633M 619M 26.69B
Net income -227M -22.7M -20.27M -18.86M -17.16M -32.39M -2.2B -32.53M -88.94M -1.12B -85.25M -83.39M -3.59B -126M -12.6M -11.25M -10.47M -9.52M -17.98M -1.22B -18.06M -49.37M -622M -47.32M -46.28M -2B
Net Debt -69M -6.9M -6.16M -5.73M -5.21M -9.85M -668M -9.89M -27.04M -340M -25.91M -25.35M -1.09B -166M -16.6M -14.83M -13.79M -12.55M -23.69M -1.61B -23.79M -65.04M -819M -62.34M -60.98M -2.63B
Logo Cellink AB
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Cellink AB